Moody’s gives Ansell acquisition a thumbs up
Moody’s gave Ansell approval this week following the company’s proposed $641 million acquisition of Kimberley-Clark’s PPE business.
Read More
For over a century, Ansell has delivered the most advanced protection solutions to millions of people…at work, at home and in harm’s way.
This year 2018, is a very special milestone at Ansell, as it was 125 years ago that our story began. Our journey started in 1893 when John Boyd Dunlop established the Australian branch of the Dunlop Pneumatic Tyre Company to manufacture bicycles in Melbourne, Australia. One of the mechanics employed there was a hard-working young man named Eric Norman Ansell.
In 1905, Eric Ansell recognized an opportunity when his employer was looking to dispose of some manufacturing equipment. With this discarded machinery, he founded what was to become the Ansell Rubber Company, initially a balloon & condom company that eventually expanded into surgical, household and work gloves.
In the years since, millions of people have come to rely on Ansell’s innovative products and safety solutions to protect them at home or on the job. The same dedication to quality and innovation that started with Eric Ansell, continues today, as Ansell has grown to serve 25 global industries in 120 countries in ways that shape and protect our modern world.
Moody’s gave Ansell approval this week following the company’s proposed $641 million acquisition of Kimberley-Clark’s PPE business.
Read More
Big investors seized a lucrative opportunity on Tuesday as Ansell, the global leader in protective solutions, executed a $400 million placement. The move, aimed at financing the acquisition of Kimberley-Clark's PPE business, resulted in significant gains for shareholders across the board.
Read More
Medical products and protective wear group, Ansell (ASX:ANN) had its shares suspended on Monday ahead the announcement of its proposed acquisition of the personal protective equipment business of giant US paper products group, Kimberley-Clark.
Read More
Ansell (ASX:ANN), like other major industrial players this interim reporting season, has followed suit in 'narrowing' its earnings guidance without explicitly signaling a potential reduction in results by June 30.
Read More
The decline of the Covid-19 boom has continued to adversely affect Ansell during 2022-23. However, the management is optimistic about improving conditions.
Read More
The target price eases to $27.53 from $28.95, and the Hold rating is maintained.
Read More
Macquarie sees price as a more relative factor in the 2H and on current dynamics, retains Sell. Target falls to $30.70 from $32.00.
Read More
Macquarie downgrades to Underperform from Neutral. Target is lowered to $32.00 from $39.00.
Read More
Ansell will report its first-half results on 16 February and expects to deliver organic growth above 20%, higher than Credit Suisse's previous forecast of 14%. Outperform retained. Target is raised to $45.50 from $45.
Read More
Ansell released a trading update with higher growth guidance for the full financial year. UBS analysts, in response, have increased forecasts by 4% for FY21. Target price is $39.60. Neutral rating retained.
Read More